Arcturus Therapeutics Holdings Inc. (ARCT) return on invested capital (ROIC)

Return on invested capital · fiscal 2025
-746.2%

Arcturus Therapeutics Holdings Inc. (ARCT) earned a return on invested capital of -746.2% in fiscal 2025 (the year ended December 31, 2025). That is 513.6 percentage points lower than the -232.5% of fiscal 2024. Figures as of 17 Nov 2026, 23:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on invested capital, fiscal 2025
-746.2%
Change on fiscal 2024
−513.6 pts
Highest on record
-232.5%fiscal 2024
Lowest on record
-746.2%fiscal 2025
Fiscal years on record
32023–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Arcturus Therapeutics Holdings Inc. return on invested capital (ROIC), in more detail

Across the 3 fiscal years on record (2023–2025), the highest was -232.5% in fiscal 2024 and the lowest -746.2% in fiscal 2025.

History · 3 fiscal years

Return on invested capital by fiscal year

Arcturus Therapeutics Holdings Inc. return on invested capital (ROIC), year by year

Arcturus Therapeutics Holdings Inc. (ARCT) return on invested capital (ROIC) by fiscal year
Fiscal yearReturn on invested capitalChangeYear ended
2025-746.2% 513.6 pts down
2024-232.5% 136.9 pts up
2023-369.4%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

How to read it

It measures how well the business turns capital into profit whoever supplied it; a figure above the cost of that capital, roughly 8–10%, means growth creates value.

More on ARCT

Arcturus Therapeutics Holdings Inc., figure by figure

Arcturus Therapeutics Holdings Inc. (ARCT) overview: price, valuation and scorecard

Arcturus Therapeutics Holdings Inc. return on invested capital (ROIC): questions and answers

What is Arcturus Therapeutics Holdings Inc.'s return on invested capital?

Arcturus Therapeutics Holdings Inc. (ARCT) earned a return on invested capital of -746.2% in fiscal 2025 (the year ended December 31, 2025). That is 513.6 percentage points lower than the -232.5% of fiscal 2024.

What are the highest and lowest return on invested capital figures on record for Arcturus Therapeutics Holdings Inc.?

Across the 3 fiscal years on record (2023–2025), the highest was -232.5% in fiscal 2024 and the lowest -746.2% in fiscal 2025.

How is Arcturus Therapeutics Holdings Inc.'s return on invested capital calculated?

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Arcturus Therapeutics Holdings Inc. (ARCT) return on invested capital (ROIC)”, data as of 17 November 2026. https://funkfolio.com/stock/ARCT/roic

Underlying data: the company's filings with the SEC and Yahoo Finance.